Tertiapin Q
Quick Overview for Tertiapin Q (ABIN1540134)
Target
Application
-
-
Purpose
- Tertiapin is a Kir channel blocker
-
Sequence
- Ala-Leu-Cys3-Asn-Cys5-Asn-Arg-Ile-Ile-Ile-Pro-His-Gln-Cys14-Trp-Lys-Lys-Cys18-Gly-Lys-Lys-NH2Disulfide bonds between Cys3-Cys14 and Cys5-Cys18
-
-
-
Restrictions
- For Research Use only
-
-
-
- Tertiapin Q
-
Background
- Tertiapin has been isolated from the venom of the Honeybee Apis mellifera (African tarantula). Tertiapin-Q is a mutant of tertiapin where M13 has been mutated by Q in order to increase your stability. This is a neurotoxin with presynaptic activity that blocks the inwardly rectifying Kir1.1 (KCNJ1) and Kir3.1/3.4 (KCNJ3/KCNJ5) potassium channels with high affinity by binding to the M1-M2 linker region of thesechannels in a 1:1 stoichiometry. Tertiapin-Q also inhibits calcium-activated large conductance BK-type (KCNMA/KCNMB) potassium channels in a concentration, and voltage-dependent manner, in addition to inhibiting Kir3.1/3.2 (KCNJ3/KCNJ6) heteromultimer potassiumchannels.
-
Molecular Weight
- 2453.39 Da
-
CAS-No
- 252198-49-5
Target
-